FULVESTRANT
NDC 70771-1626, fulvestrant, injection, solution, from Zydus Lifesciences Limited.
- Product NDC
- 70771-1626
- Status
- Listed
- Labeler
- Zydus Lifesciences Limited
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215234
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1626 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FULVESTRANT50 mg/mL
Pharmacologic classes
Estrogen Receptor Antagonist [EPC]; Estrogen Receptor Antagonists [MoA]; Selective Estrogen Receptor Modulators [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70771-1626-8 | 70771162608 | 2 SYRINGE, GLASS in 1 CARTON (70771-1626-8) / 5 mL in 1 SYRINGE, GLASS (70771-1626-2) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/151b948a-3106-497a-b1c7-479307faeb89
Use it
Look up 70771-1626 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1626 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70771-1626. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.